Age Care Labs runs elder care services across home-based support and assisted living. It has now raised ₹85 crore in a Series B1 round to push deeper into senior living. The company is betting that Indian families don’t just need emergency help for ageing parents — they need a full care continuum that can stretch from at-home monitoring to residential support and independent living. Founded in 2019 by Saumyajit Roy, Age Care Labs operates through Emoha and Epoch Elder Care, with Epoch led by co-founder Neha Sinha. That mix makes this round more interesting than a standard healthcare funding headline.
What does Age Care Labs do and how does it work?
At a basic level, Age Care Labs sells organised elder care in three layers. Emoha handles ageing at home. Epoch handles assisted living and higher-acuity residential care. The new Shremoha venture is meant for premium independent senior living. That means one company can now meet seniors when they’re still living on their own, when they need structured help, and when they want a purpose-built community instead of a standard apartment block.
For an Emoha customer, the workflow is specific. A care specialist assesses the senior’s health, mobility, medical history, and day-to-day needs. Then they map those needs to a plan with digital medical records, scheduled monitoring, and emergency coordination. Depending on the plan, the service can include doctor teleconsults, ambulance evacuation, lab tests, physiotherapy access, home safety assessments, medicine support, and hospital or appointment accompaniment.
What stands out is the attempt to remove a lot of invisible family labor. Emoha uses recurring check-in calls — branded in some plans as support from an “Emoha Daughter” — to keep tabs on medicines, tests, appointments, and chronic-condition management. For urban professionals living away from parents, that’s the actual product. Not just medical care, but a system that absorbs coordination work families usually do in panic mode.
Epoch is the heavier-care side of the business. It runs elder care homes for seniors who need help with activities of daily living. It offers 24×7 assisted living, dementia care, Parkinson’s care, palliative care, rehabilitation, and skilled nursing. So Age Care Labs isn’t pitching a single app. It’s building a care ladder.
Who founded Age Care Labs and why are they credible?
The founding story
Roy didn’t come into this category by accident. He built Age Care Labs around the idea that older adults should be able to stay independent for as long as possible, with structured help wrapped around them rather than dumped on family members. Epoch came from a different starting point — more clinical, more residential, more focused on dementia and long-term elder support. That gives the combined platform a wider operating base than most single-format elder care brands.
Founder market fit
Roy’s background fits the category unusually well. Before Emoha, he worked at Antara Senior Living, founded Ignox Labs, and spent time at Jones Lang LaSalle in social infrastructure. He studied planning at the School of Planning and Architecture in New Delhi and later earned an MBA from the Indian School of Business. In plain English: he understands care, housing, and how to build service businesses around both.
Sinha brings the clinical depth. She’s a clinical psychologist and dementia specialist who started her career with Sanjivini Society for Mental Health, worked in psychiatric rehabilitation, and later helped shape Epoch from a home-care provider into an assisted-living operator. She’s also trained in palliative care. That matters because dementia and end-of-life care aren’t side services here — they’re core operating disciplines.
Traction, fundraising, and competition
The company already has some scale. Roy said Age Care Labs is serving around 300,000 seniors across 40 Tier I and II cities. Epoch now has 6 assisted living homes across Gurgaon and Pune with about 200 rooms, and the broader platform has raised $29 million to date while following an asset-light, technology-first model.
This latest cheque is ₹85 crore, or about $9 million, in a Series B1 round. Shrem Group led it, with participation from Rainmatter, Pegasus Finvest, and family offices. The round sits inside a larger planned Series B raise of ₹250 crore that the company expects to complete in Q1 2027. Age Care Labs had already drawn backing from Lumis Partners, Rainmatter, Gruhas, and KOIS Invest before this round.
Competition is fragmented, which is both good and messy. On the home-care side, organised players include Samarth, Yodda, and Portea. In residential senior care and assisted living, Antara, Athulya, and Primus are among the better-known names. Age Care Labs’ pitch is that most rivals specialise in one slice, while it wants to own the journey from home monitoring to assisted living and now independent senior communities through Shremoha. It’s a stronger story — if execution holds.
Why are investors backing Age Care Labs now?
Because this round changes the shape of the business.
Age Care Labs wasn’t just raising growth capital. It also signed a strategic partnership with Shrem Group to launch Shremoha, a premium senior independent living platform. That matters because residential senior living needs real-estate and hospitality muscle as much as care expertise, and Shrem brings exactly that. Roy called the new venture “a natural extension” of the company’s existing experience, adding, “Our ambition is to build communities where seniors are not just cared for but are active, connected, and fully alive.”
The funding will go into service expansion and technology. It will also support stronger healthcare capabilities and broader growth across India. Read between the lines and the strategy is obvious: Age Care Labs wants tighter control over the elder care stack, from remote monitoring and coordination to premium physical communities. That’s ambitious. It won’t be cheap, but it’s more defensible than staying a light-touch concierge brand forever.
Shrem Group’s thesis also sounds direct. Founder and managing director Nitan Chhatwal said India’s next generation of seniors is more independent and more focused on quality of life, and that Shremoha is meant to match that expectation with real estate, hospitality, preventive healthcare, wellness, emergency response, and coordinated care. Investors aren’t just backing elder care demand here. They’re backing the rise of senior lifestyle infrastructure.
How big is India’s senior living market?
The demographic case is huge. The source article cites a CareEdge Ratings estimate that India’s 60-plus population will rise to about 231 million by 2036 from roughly 142 million in 2021, creating a specialised senior care market worth around $35 billion a year. That’s already enough to explain why capital keeps showing up. It still probably understates how much demand sits outside organised providers.
The housing side is also getting bigger. Grand View Research estimates India’s senior housing market at $2.06 billion in 2024 and projects it will reach $3.23 billion by 2030, growing at a 7.78% CAGR. Its report also points to the same forces operators keep talking about: nuclear families, greater mobility, rising acceptance of senior living, and older Indians wanting better housing rather than just medical fallback options.
The market isn’t just about old-school retirement towns anymore. Developers are increasingly building in or near major cities because wealthier retirees want to stay close to family, hospitals, and city amenities. Grand View also notes that returning NRIs are part of the demand story, especially for higher-quality communities with hospitality and healthcare built in. That urban shift lines up neatly with what Age Care Labs and Shrem are trying to build.
What happens after Age Care Labs funding?
Age Care Labs now has a chance to become more than an elder care operator.
If Shremoha launches well and the rest of the ₹250 crore Series B closes on schedule in Q1 2027, the company could end up owning one of the more complete senior care models in India — home care, assisted living, and independent living under one umbrella. That’s the upside. The harder part will be keeping service quality high while stitching together healthcare operations, hospitality standards, and real-estate execution.
Read how Venice AI raised a $65M Series A led by Dragonfly to build a privacy-first AI platform that gives users and developers access to hundreds of AI models without storing prompts or conversation history.
FAQ
- What is the Age Care Labs funding round about? Age Care Labs has raised ₹85 crore in a Series B1 round led by Shrem Group, with participation from Rainmatter, Pegasus Finvest, and family offices. The round is part of a larger planned ₹250 crore Series B that the company expects to complete in Q1 2027, and the money is meant to support expansion across services, healthcare capabilities, and senior living.
- How does Age Care Labs work for seniors and their families? It works as a multi-format elder care platform. Emoha supports seniors at home with monitoring, emergency coordination, teleconsults, records, and appointment help. Epoch offers 24×7 assisted living, dementia care, palliative care, rehabilitation, and nursing for seniors who need more intensive support.
- Who founded Age Care Labs and what is their background? Age Care Labs was founded in 2019 by Saumyajit Roy, who previously worked at Antara Senior Living and Jones Lang LaSalle and also founded Ignox Labs. The platform’s residential and dementia-care depth comes from Epoch leader Neha Sinha, a clinical psychologist and dementia specialist with palliative-care training and years of operating experience in elder care.
- Is Age Care Labs a healthtech company or a senior living company? It’s both, and that’s the point. Age Care Labs sits in the organised elder care category, combining tech-enabled home care with assisted living and now independent senior living through Shremoha, which puts it somewhere between a healthcare services company and a senior housing operator.
